Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Garniglipt 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Garnet Pharmaceutical

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Garniglipt 50/500 Tablet

Diabex Duo 50/500 tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo 50/500 may be used independently or alongside other diabetes treatments. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical guidance. Effective blood sugar control reduces the likelihood of future complications. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly influence diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and treat this condition. This medication is not universally suitable. Consult your physician before use if you have kidney, liver, or heart disease, pancreatic issues, or consume excessive alcohol. Pregnant or lactating women should seek medical advice. Interactions with other medications are possible; inform your doctor about all your current medications for safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and glucose levels throughout your treatment.

Uses of Garniglipt 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Garniglipt 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Garniglipt 50/500 Tablet should be administered with a meal.

Common Side effects of Garniglipt 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Garniglipt 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Garniglipt 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Garniglipt 50/500 Tablet works:

Each Garniglipt 50/500 Tablet combines two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Garniglipt 50/500 Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Garniglipt 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Garniglipt 50/500 tablets are likely incompatible. Available data in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney disease should exercise caution when using Garniglipt 50/500 Tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Garniglipt 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Garniglipt 50/500 Tablet :

Should you forget to take your Garniglipt 50/500 Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Garniglipt 50/500 Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Garniglipt 50/500 Tablet

Garniglipt 50/500 Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can occur if inadequate calories are consumed. Symptoms, such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness, may appear, especially if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advised.
Nausea and vomiting are possible side effects of Garniglipt 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Garniglipt 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Garniglipt 50/500 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Garniglipt 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Garniglipt 50/500 Tablets and seek immediate medical attention.
Prolonged Garniglipt 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Garniglipt 50/500 Tablet is safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Garniglipt 50/500 Tablet
54
MRP 66
18% off